Dr. Symmans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- NYU Grossman School of MedicineResidency, Immunopathology, 1993 - 1995
- University of Texas M D Anderson Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1992 - 1993
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1988 - 1992
- University of Auckland Faculty of Medicine and Health SciencesClass of 1986
Certifications & Licensure
- TX State Medical License 2000 - 2025
- NY State Medical License 1996 - 2003
- PA State Medical License 1992 - 1996
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy.Akram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, Raul Mendez-Giraldez, Azam Yazdani
Communications Medicine. 2025-01-08 - Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer.Qiqi Ye, Timothy Law, Dianna Klippel, Constance Albarracin, Hui Chen
Modern Pathology. 2025-01-07 - 5 citationsNeoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen
Breast Cancer. 2024-09-01
Press Mentions
- Residual Cancer Burden Predicts Outcomes for All Breast Cancer TypesFebruary 25th, 2020
Committees
- Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: